## Lithium's Mechanism of Action **Key Point:** Lithium's primary mood-stabilizing mechanism is inhibition of inositol monophosphatase (IMPase), which depletes intracellular inositol and reduces phosphatidylinositol (PI) cycle signaling. ### The Inositol Depletion Hypothesis ```mermaid flowchart TD A[Lithium enters cell]:::action --> B[Inhibits inositol monophosphatase]:::action B --> C[Reduces IP3 recycling to free inositol]:::action C --> D[Depletion of intracellular inositol pool]:::outcome D --> E[Decreased PI cycle signaling]:::outcome E --> F[Reduced neuronal excitability]:::outcome F --> G[Mood stabilization]:::outcome ``` ### Biochemical Details 1. **Target enzyme:** Inositol monophosphatase (IMPase) catalyzes the final step of inositol-1,4,5-trisphosphate (IP₃) recycling 2. **Effect:** Lithium inhibits IMPase, preventing conversion of inositol monophosphate back to free inositol 3. **Consequence:** Intracellular inositol becomes depleted, reducing the availability of phosphatidylinositol for resynthesis 4. **Result:** Diminished PI cycle signaling → reduced neuronal excitability and neurotransmitter release **High-Yield:** The "inositol depletion hypothesis" is the most widely accepted mechanism, though lithium has multiple cellular effects (GSK-3β inhibition, protein kinase C modulation) that may contribute. ### Clinical Correlates **Clinical Pearl:** Lithium's onset of mood-stabilizing action is slow (7–14 days), consistent with gradual depletion of intracellular inositol pools rather than immediate receptor blockade. **Mnemonic:** **LIMP** = **L**ithium **I**nhibits **M**onophosphatase, **P**reventing inositol recycling
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.